Injective (INJ) Token Sees Short-Term Surge Amidst Long-Term Bearish Outlook
The Injective (INJ) token has recently captured significant attention, experiencing a notable price surge amidst crucial developments for the Layer 1 blockchain. While short-term catalysts have fueled this upward momentum, investors are urged to consider the broader market context and technical indicators that paint a more complex picture for its future trajectory.
Catalysts for INJ's Recent Ascent
INJ witnessed an impressive 35% rally, climbing from $2.97 to $4.02, accompanied by a substantial 57% increase in trading volume. This significant upward movement was primarily driven by two key developments. Firstly, the finance mortgage platform Pineapple announced a $2 million acquisition of INJ tokens, further committing $20.79 million in capital reserves for continued accumulation. Secondly, the Injective real-time EVM mainnet upgrade went live, providing additional bullish impetus. These positive announcements converged during a period of otherwise sideways price action, propelling the token higher in the short term.
Navigating Long-Term Trends and Future Prospects
Despite the recent gains, the long-term trend for the Injective token remains cautiously bearish, characterized by a series of lower highs and lower lows since September 2025. Technical analysis indicates persistent capital outflows, even as the Relative Strength Index (RSI) briefly moved above the neutral 50-mark. Looking ahead, INJ is likely to face immediate resistance around the $4.16 and $6.09 levels. While a short-term retracement towards the $3.44 and $3.28 range is anticipated in the coming days, any subsequent move towards these higher resistance points would require a significant and sustained breakout to signal a reversal of the prevailing long-term downtrend and establish a new bullish phase.
